FUJI LATEX (5199) FY2026 Q3 Earnings Report

Quick View

Executive Summary

Cumulative results for Q3 resulted in lower revenue but higher earnings. Although Operating Income and Ordinary Income improved significantly, the Company did not achieve an increase in final profit due to the impact of extraordinary losses. Revenue was ¥51.1B (-7.0% YoY), Operating Income was ¥3.6B (+88.1% YoY), Ordinary Income was ¥3.0B (+81.1% YoY), and Net Income attributable to owners of the parent was ¥1.0B (approximately unchanged from the previous year; EPS was -2.2% YoY). The improvement at the operating level appears to have been primarily attributable to a lower cost ratio and more efficient SG&A expenses; however, extraordinary losses of ¥1.7B, including an impairment loss of ¥1.5B, were recorded, and Net Income did not fully reflect the benefit of the improvement in Operating Income.

Factors Affecting Results

【Revenue】Revenue was ¥51.1B, a 7.0% decrease YoY. By segment, the core PrecisionEquipment segment generated ¥32.7B (64.0% composition ratio) and secured a high profit margin of 24.2%, while MedicalEquipment generated ¥16.4B (32.1% composition ratio), with a profit margin of only 3.6%. SP is small at ¥0.6B but recorded an operating loss, indicating variability in profitability across the business portfolio.

【Profit and Loss】Operating Income improved significantly to ¥3.6B (+88.1% YoY), and Ordinary Income to ¥3.0B (+81.1% YoY), but non-operating expenses of ¥0.7B, including interest expenses of ¥0.5B, pressured Ordinary Income. In addition, extraordinary losses of ¥1.7B, including an impairment loss of ¥1.5B on fixed assets and other assets, were recorded, reducing Profit Before Tax to ¥1.5B and leaving Net Income at ¥1.0B, approximately unchanged from the previous year. The improvement in Operating Income despite lower revenue can be characterized as lower revenue but higher earnings; however, the impact on final profit was limited by extraordinary losses.

Segment Analysis

By segment, Operating Income from PrecisionEquipment was ¥7.9B (profit margin: 24.2%), making it the earnings pillar, while MedicalEquipment generated only ¥0.6B (profit margin: 3.6%). SP recorded an operating loss of ¥0.4B (profit margin: -69.1%), reflecting deteriorating profitability and weighing on overall earnings despite its small scale. The majority of consolidated Operating Income of ¥3.6B was driven by PrecisionEquipment, and the disparity in profit margins between businesses is a structural characteristic.

Key Financial Indicators

【Profitability】Although the Operating Income margin improved to 7.0% (3.5% in the previous year), the Net Income margin remained at 1.9%, with the SG&A expense ratio of 19.7% compressing profit relative to the gross profit margin of 26.8%. 【Cash Quality】Days sales outstanding were 76 days on an annualized basis, inventory turnover days were 149 days, and the cash conversion cycle was 203 days, indicating a structure in which it takes time to convert earnings into cash. 【Investment Efficiency】ROE was 2.3% and total asset turnover was 0.472x, indicating limited capital efficiency. 【Financial Soundness】The Equity Ratio was 37.5% (36.8% in the previous year), while interest-bearing debt was ¥43.8B. Of this amount, short-term borrowings of ¥28.6B accounted for 26.3% of total assets, indicating a high dependence on short-term liabilities. The current ratio was 128.2% and the quick ratio was 116.0%, ensuring a sufficient level of short-term asset capacity.

Cash Flow Analysis

As disclosed figures from the statement of cash flows are unavailable, funding trends are examined based on changes in the balance sheet. Cash and deposits were ¥22.2B, down from ¥23.4B in the previous year, while accounts receivable were ¥14.1B and inventories were ¥6.0B, with both tying up a considerable amount of funds in working capital. Days sales outstanding of 76 days and inventory turnover days of 149 days indicate a structure in which it takes time for earnings to be collected as cash. Short-term borrowings were ¥28.6B and long-term borrowings were ¥15.2B. Short-term debt accounted for a high proportion of total interest-bearing debt of ¥43.8B, indicating a notable dependence on refinancing in terms of funding.

Quality of Earnings

Current-period earnings comprise a mixture of recurring earnings improvements and temporary factors. While the improvements in Operating Income and Ordinary Income appear to have been driven by recurring factors such as a lower cost ratio and greater SG&A efficiency, the ¥1.5B impairment loss included in extraordinary losses of ¥1.7B was a temporary factor and significantly reduced Profit Before Tax to ¥1.5B and Net Income to ¥1.0B. In non-operating income and expenses, non-operating expenses of ¥0.7B, including interest expenses of ¥0.5B, exceeded non-operating income of ¥0.2B, creating a structure in which profit was compressed even at the Ordinary Income level. Comprehensive Income was ¥1.0B, approximately in line with Net Income, and no significant divergence attributable to valuation items such as the valuation difference on securities was observed.

Earnings Forecast and Guidance

Progress against the full-year forecast was 75.8% for Revenue, 97.8% for Operating Income, and 104.1% for Ordinary Income, indicating that earnings are progressing at a pace that is nearly achieving or exceeding the plan. Meanwhile, cumulative actual Net Income of ¥1.0B has already exceeded the full-year Net Income forecast of ¥0.35B, suggesting that the full-year forecast may have been set conservatively to incorporate additional factors such as impairment losses. Revenue progress was broadly consistent with the 75% quarterly benchmark and can be described as tracking in line with the full-year forecast for a 6.3% decrease in revenue.

Shareholder Returns

The full-year forecast dividend is ¥80 per share. Based on the full-year forecast EPS of ¥27.98, the Payout Ratio is approximately 286%, representing a dividend level exceeding single-year earnings. Retained earnings of ¥28.4B provide a source for dividends in the short term; however, restoring earnings or cash flow will be a challenge for maintaining the dividend level on an ongoing basis.

Risk Factors

1. Refinancing and liquidity risk: The Company has interest-bearing debt of ¥43.8B, including short-term borrowings of ¥28.6B. The ratio of short-term liabilities is high relative to the level of current liabilities, making the Company susceptible to refinancing conditions and rising interest rates.

2. Working capital efficiency risk: Days sales outstanding of 76 days, inventory turnover days of 149 days, and a cash conversion cycle of 203 days are lengthy, tying up funds in trade receivables and inventories.

3. Asset profitability and additional impairment risk: An impairment loss of ¥1.5B was recorded during the current period. Depending on the utilization status of property, plant and equipment of ¥41.5B (38.3% of total assets), additional impairment losses may occur.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The Company's profitability is below the industry median for both metrics. In particular, the Net Income margin ranks low within the industry, partly due to the impact of extraordinary losses.

Growth and Capital Efficiency

The Revenue growth rate is significantly below the industry median, placing the Company among those experiencing a notable degree of revenue decline within the industry.

※Source: Compiled by the Company

Key Points in the Earnings Results

1. Operating Income improved significantly, increasing 88.1% YoY; however, the improvement occurred while Revenue declined 7.0%, leaving room to assess whether improvements in the cost and expense structure are sustainable.

2. Despite the improvement in Operating Income, Net Income remained approximately unchanged from the previous year, as extraordinary losses, including the ¥1.5B impairment loss, weighed on final profit. To assess underlying recurring earnings power, the impact of extraordinary income and expenses should be analyzed separately.

3. The Company has a high dependence on short-term borrowings, while the turnover periods for accounts receivable and inventories are lengthy. Accordingly, whether the improvement in earnings is translating into actual cash generation will be a key point for future monitoring.

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 performance showed a substantial recovery in operating profitability despite a 7.0% year-on-year decline in cumulative revenue. Revenue was ¥5.113bn, while operating income rose 88.1% to ¥360m. Gross profit increased 17.2% to ¥1.369bn, indicating that the earnings improvement was led by a sharp recovery in gross margin rather than revenue growth. Gross margin expanded to 26.8% from 21.2% in the prior-year period, a 560bp improvement. SG&A expenses increased 3.3% to ¥1.009bn, materially below the pace of gross-profit growth. As a result, operating margin improved to 7.0% from 3.5%, a 350bp expansion. Ordinary income rose 81.1% to ¥303m, but the conversion from operating income was constrained by ¥50m of interest expense and ¥9m of foreign-exchange losses. Net income attributable to owners declined 2.2% to ¥95m despite the operating recovery. The principal reason was a ¥168m extraordinary loss, including a ¥152m impairment loss. The impairment alone was equivalent to about 160% of reported net income, while the broader one-time-item alert is 172.1% of net income, making statutory earnings highly non-recurring in composition. The tax burden was also relatively high, with an effective tax rate of 35.7% and a tax-burden factor of 0.641. The balance sheet remains adequately liquid on a current-ratio basis, with current assets of ¥6.310bn against current liabilities of ¥4.921bn. However, the funding structure is short-term-debt-heavy: short-term loans were ¥2.857bn and the short-term debt ratio was 65.3%. Manufacturing working-capital efficiency is a key concern, with annualized DSO of 76 days, annualized DIO of 149 days, and an annualized cash conversion cycle of 203 days. Full-year operating-income progress is strong at 97.8% after nine months, whereas revenue progress is broadly normal at 75.8%. Full-year net-income progress is unusually high at 271.4% because the ¥35m forecast incorporates the Q3 impairment and implies a weak final-quarter net-income outcome. The central forward issue is whether the restored gross margin can be sustained while the company reduces working-capital intensity, refinancing exposure, and impairment risk.

Profitability Analysis

The reported annualized ROE is 3.1%, decomposed into a 1.9% net profit margin, 0.629x annualized asset turnover, and 2.67x financial leverage. The weakest component is the net margin, which remains below the 3% concern threshold despite the strong operating-income recovery. Financial leverage supports the reported ROE, but this is not a high-quality source of shareholder return because interest-bearing debt is substantial relative to equity. The largest year-on-year change was in operating profitability: gross margin expanded 560bp and operating margin expanded 350bp to 7.0%. This indicates that the company achieved a significant improvement in production, procurement, pricing, product mix, or utilization economics sufficient to offset a 7.0% revenue contraction. SG&A increased only 3.3%, versus the 17.2% rise in gross profit, demonstrating favorable operating leverage below the gross-profit line. Operating margin of 7.0% has improved meaningfully but remains below the 8-15% benchmark generally regarded as good. The five-factor DuPont analysis identifies interest burden as the major drag: the EBT/EBIT factor was only 0.412, meaning approximately 59% of EBIT was absorbed by net interest and other pre-tax non-operating costs. This explicitly addresses the high-interest-burden alert; the root cause is ¥50m of interest expense against ¥360m of EBIT, and the 7.26x interest-coverage ratio is adequate but not ample for a cyclical manufacturer. The tax-burden factor of 0.641 also constrained the conversion of pre-tax profit into net income. The ¥152m impairment loss was the decisive reason that the operating turnaround did not reach the bottom line. The operating-margin improvement appears more sustainable than the net-income result, but sustainability depends on maintaining gross-margin gains amid lower sales volumes and avoiding additional impairment charges.

Growth Assessment

Revenue declined 7.0% year on year to ¥5.113bn, indicating that the earnings recovery was not volume-led. Gross profit nevertheless increased by ¥201m, demonstrating a materially improved gross-profit yield on the existing revenue base. The Q3 cumulative operating-income result of ¥360m is only ¥8m below the full-year forecast of ¥368m, producing a 97.8% progress rate versus the standard 75% Q3 pace. Ordinary income of ¥303m already exceeds the full-year forecast of ¥291m, or 104.1% progress. Revenue progress of 75.8% is closely aligned with the standard Q3 progression, so the forecast does not require an unusually strong sales finish. The full-year operating-income forecast implies that nearly all projected annual operating profit has already been generated, making fourth-quarter margin preservation more important than incremental profit growth. Forecast net income of ¥35m is far below the Q3 cumulative ¥95m, producing a 271.4% progress rate; this unusual relationship reflects the impact of extraordinary losses and indicates that net income is not a useful indicator of underlying operating momentum in isolation. The reduced revenue base remains a constraint on growth quality, because favorable margins must compensate for lower throughput. The manufacturer also faces elevated inventory intensity, with annualized DIO of 149 days, which can signal slow-moving stock, an extended production cycle, or demand uncertainty. Annualized DSO of 76 days is above the 60-day warning level and raises the risk that sales growth or reported revenue may not translate promptly into cash collections. The annualized cash conversion cycle of 203 days is therefore a material hurdle to self-funded growth. The ¥59m intangible-asset balance is only 0.5% of total assets, so the increase in intangibles does not create a large asset-concentration issue. The growth outlook is most sensitive to the durability of gross-margin improvement, inventory normalization, customer collection discipline, and the absence of further asset impairments.

Financial Health

Liquidity is acceptable but not abundant. The current ratio is 128.2% and the quick ratio is 116.0%, with working capital of ¥1.389bn; therefore, current assets exceed current liabilities and there is no current-ratio-below-1.0 warning. Cash and deposits of ¥2.216bn cover 0.78x short-term debt, leaving the company dependent on operating cash generation and refinancing rather than cash alone to address near-term borrowings. Current liabilities totaled ¥4.921bn, including ¥2.857bn of short-term loans, ¥406m of current maturities of long-term loans, and ¥300m of current bonds. This explicitly addresses the refinancing-risk alert: the 65.3% short-term debt ratio is well above the 40% alert threshold, creating a maturity mismatch risk even though current assets exceed current liabilities. Total liabilities were ¥6.778bn, equivalent to 62.5% of total assets, while total equity was ¥4.066bn and the capital adequacy ratio was 37.5%. Debt-to-equity was 1.67x, below the explicit 2.0x high-leverage warning threshold but still elevated for a small manufacturer with modest net margins. Debt/capital of 51.8% is also above the 40% investment-grade benchmark, though below the 60% concern level. Interest coverage of 7.26x is currently serviceable, but the low 0.412 interest-burden factor shows that financing costs materially suppress pre-tax earnings. Total assets declined 1.9% year on year to ¥10.843bn, while equity was essentially unchanged, limiting balance-sheet deterioration. PPE remained substantial at ¥4.154bn, or 38.3% of assets, which is consistent with a capital-intensive manufacturing base. Intangible assets increased 57.9% to ¥59m, but at just 0.5% of assets this movement is immaterial to solvency and does not materially alter impairment exposure. The main financial-health priority is lengthening debt maturities or increasing liquidity buffers while reducing the working-capital cash requirement.

Notable B/S Changes

Intangible assets: +¥21m (+57.9%) to ¥59m - the percentage increase is large, but the balance remains only 0.5% of total assets and is not material to overall balance-sheet risk. Land: -¥137m (-7.7%) to ¥1.640bn - lower land carrying value contributed to the modest year-on-year decline in noncurrent assets and should be considered alongside the period’s impairment charge. Bonds payable: -¥300m (-75.0%) to ¥100m, while ¥300m is classified as current bonds - debt maturity has shifted toward the current portion, reinforcing refinancing-risk monitoring. Work in process: +¥66m (+11.6%) to ¥631m - the increase occurred alongside a 7.0% revenue decline and contributes to the elevated annualized inventory days and cash conversion cycle.

Cash Flow Quality

The cash-conversion profile is a material earnings-quality concern. Annualized DSO of 76 days exceeds the 60-day warning threshold, indicating comparatively slow collection of trade receivables. Annualized DIO of 149 days exceeds the 90-day warning threshold and is particularly high for a manufacturer, raising risks of inventory carrying costs, markdowns, obsolescence, and further write-downs if demand weakens. The annualized cash conversion cycle of 203 days is far above the 120-day warning threshold. This explicitly addresses the high-receivable-days, high-inventory-days, and long-CCC alerts: the root cause is that cash is tied up for an extended period in customer credit and inventories relative to supplier financing. The impact is heightened because short-term debt accounts for 65.3% of debt, so working-capital absorption can translate directly into refinancing needs. Raw materials were ¥807m, work in process was ¥631m, and finished goods were ¥600m, showing meaningful capital tied across production stages. Work in process represented approximately 31% of the disclosed manufacturing inventory categories, below the 40% production-bottleneck warning benchmark, although the aggregate inventory cycle remains long. Accounts receivable were ¥1.413bn and electronically recorded monetary claims were ¥508m, reinforcing the importance of collection discipline. Accounts payable were ¥294m and electronically recorded obligations were ¥376m; these supplier obligations provide some funding but do not offset the extended operating cycle. The sharp increase in operating income is encouraging, but the long cash cycle means the quality of this recovery depends on conversion into cash rather than accrual profit. The impairment loss also indicates that a portion of the asset base did not meet expected recoverability, which warrants close monitoring of inventory and fixed-asset returns. Operating cash flow, free cash flow, and cash conversion versus net income are not quantified here; the working-capital indicators should therefore be treated as the available evidence on cash-flow risk.

Dividend Sustainability

The full-year dividend forecast is ¥80 per share, compared with forecast EPS of ¥27.98. This implies a dividend payout ratio of approximately 286%, well above the 100% warning threshold. The forecast dividend is also above the ¥78 per share paid in the prior period. The elevated payout ratio is driven by unusually low forecast net income, which reflects the large impairment charge rather than weak operating income alone. Even so, dividends would exceed forecast earnings by a substantial margin and would need to be supported by retained earnings, cash resources, or debt capacity rather than current-year profit. Retained earnings were ¥2.835bn, providing a balance-sheet buffer, but cash and deposits of ¥2.216bn are below short-term debt of ¥2.857bn. The high working-capital requirement and short-term refinancing exposure make preservation of liquidity important. No buyback information is used in this assessment; accordingly, the measure is dividend payout ratio rather than total return ratio. The ¥80 dividend is not well covered by forecast earnings and should be assessed alongside operating cash conversion and refinancing conditions.

Risk Assessment

Business risks include Demand and volume risk: revenue declined 7.0% year on year, so the operating recovery relies heavily on margin improvement rather than expanding sales., Manufacturing inventory risk: annualized DIO of 149 days is above the 90-day warning level, increasing the likelihood of slow-moving inventory, obsolescence, valuation losses, and production-adjustment costs., Collection risk: annualized DSO of 76 days exceeds the 60-day alert level, increasing exposure to customer-payment delays and weaker cash realization., Industry-specific manufacturing risk: raw-material prices, energy costs, supply-chain disruption, product-quality issues, and demand volatility can quickly reverse gross-margin gains in a capital-intensive production base., Asset-utilization risk: the ¥152m impairment loss indicates that part of the fixed-asset base required a recoverability reassessment; further demand weakness could lead to additional impairment..

Financial risks include High interest burden: the 0.412 interest-burden factor means roughly 59% of EBIT was absorbed before tax by financing and other non-operating costs; this weakens earnings resilience if rates rise or EBIT falls., Refinancing risk: the 65.3% short-term debt ratio, including ¥2.857bn in short-term loans, creates a material dependence on bank funding renewal., Liquidity risk: cash covers only 0.78x short-term debt, so balance-sheet liquidity is adequate on current-ratio measures but not sufficient to repay short-term financial debt solely with cash., Leverage risk: D/E of 1.67x is below the explicit 2.0x warning threshold but remains elevated, while debt/capital of 51.8% limits flexibility., Dividend funding risk: the forecast ¥80 DPS implies a payout ratio of about 286% of forecast EPS..

Key concerns include The high-one-time-items alert is material: extraordinary losses of ¥168m, led by ¥152m impairment, caused net income to decline despite an 88.1% increase in operating income., Capital efficiency is weak: reported annualized ROE is 3.1%, and the approximately 5.0% ROIC alert indicates returns are around the minimum acceptable level and below stronger corporate-return benchmarks., The 203-day annualized cash conversion cycle combines slow receivables and high inventory days with a short-term-debt-heavy funding structure., Operating-income forecast progress of 97.8% at Q3 is favorable, but it raises the importance of avoiding a material fourth-quarter margin reversal., The quality-alert profile indicates that the investment case is more dependent on sustained operational execution and balance-sheet discipline than on the headline operating-income recovery..

Investment Implications

Key takeaways include Operating recovery is substantial: operating income increased ¥169m year on year to ¥360m despite a ¥386m decline in revenue., Gross-margin expansion of 560bp and operating-margin expansion of 350bp are the strongest confirmed improvements in the period., Net income understates operating performance because of a ¥152m impairment loss, but the impairment simultaneously raises questions about asset productivity and future write-down risk., Leverage is manageable but consequential: interest coverage is 7.26x, while high financing costs materially weaken pre-tax profit conversion., Working-capital efficiency and debt maturity management are the most important balance-sheet variables..

Metrics to watch include Gross margin and operating margin after the Q3 recovery, Revenue trend and fourth-quarter operating-income conversion versus the ¥368m full-year forecast, Annualized DSO, DIO, and cash conversion cycle, Short-term loan balance, current debt maturities, and cash-to-short-term-debt coverage, Interest expense and interest-burden factor, Further impairment charges and the carrying value/productivity of fixed assets, Dividend funding relative to earnings and operating cash generation.

Regarding relative positioning, The company’s 7.0% operating margin is materially improved from the prior-year 3.5% but remains below the general 8-15% good-profitability range. Its annualized ROE of 3.1% and approximately 5.0% ROIC are weak relative to return benchmarks, while its 203-day annualized cash conversion cycle is materially weaker than the less-than-90-day manufacturing benchmark. Liquidity ratios are above minimum warning levels, but the short-term debt concentration and elevated interest burden place it in a more financially constrained position than a conservatively financed manufacturing peer.